Cost-effectiveness of screening for amblyopia;Kosteneffektivität von screening auf amblyopie

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 2, 2005, Pages 110-116

  Neubauer, Aljoscha S ^a   Neubauer, S ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b IfG   (Germany)

Author keywords

Amblyopia; Epidemiology; Health economics; QALY; Screening

Indexed keywords

AMBLYOPIA; COST EFFECTIVENESS ANALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PROFIT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS;

AMBLYOPIA; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; INCIDENCE; MODELS, ECONOMETRIC; TREATMENT OUTCOME; VISION SCREENING;

EID: 14744276791     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813905     Document Type: Review

References (57)

1. American Academy of Ophthalmology. Preferred Practice Patterns: Amblyopia. http://www.aao.org 2002.
2. Anyanwu AC, McGuire A, Rogers CA et al. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg 2002; 123: 411-418, discussion 418-420
3. Arnold RW, Gionet EG, Jastrzebski AI et al. The Alaska Blind Child Discovery project: rationale, methods and results of 4000 screenings. Alaska Med 2000; 42: 58-72
4. Barry JC, Hartmann A, Pongs UM et al. Modell für das Nutzen-Kosten-Verhältnis des Amblyopie-Screenings. Ophthalmologe 1998; 95: 19-27
5. Barry JC, Konig HH. Non-cycloplegic screening for amblyopia via refractive findings with the Nikon Retinomax hand held autorefractor in 3 year old kindergarten children. Br J Ophthalmol 2001; 85: 1179-1182
6. Barry JC, Konig HH. Test characteristics of orthoptic screening examination in 3 year old kindergarten children. Br J Ophthalmol 2003; 87: 909-916
7. Beardsell R, Clarke S, Hill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophthalmol Strabismus 1999; 36: 19-24
8. Berufsverband der Augenärzte (BVA). Leitlinie Nr. 26a "Amblyopie". http://www.augeninfo.de 1998.
9. Brown GC, Brown MM, Sharma S et al. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 2000; 107: 1374-1380
10. Brown MM, Brown GC, Sharma S et al. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology 2003; 110: 1076-1081
11. Brown MM, Brown GC, Sharma S et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001; 108: 643-647, discussion 647-648
12. Brown MM, Brown GC, Sharma S et al. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001; 85: 327-331
13. Busbee BG, Brown MM, Brown GC et al. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002; 109: 603-612
14. Busbee BG, Brown MM, Brown GC et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003; 110: 2310-2317
15. Castiel D, Herve C, Gaillard M et al. Cost-utility analysis of early thrombolytic therapy. Pharmacoeconomics 1992; 1: 438-442
16. Cooper CD, Bowling FG, Hall JE et al. Evaluation of photoscreener instruments in a childhood population. 1. Otago photoscreener and Dortmans videophotorefractor. Aust N Z J Ophthalmol 1996; 24: 347-355
17. Dandona R, Dandona L, Srinivas M et al. Refractive error in children in a rural population in India. Invest Ophthalmol Vis Sci 2002; 43: 615-622
18. de Koning HJ, van Ineveld BM, van Oortmarssen GJ et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991; 49: 531-537
19. Flom MC, Neumaier RW. Prevalence of amblyopia. Public Health Rep 1966; 81: 329-341
20. Flynn JT, Schiffman J, Feuer W et al. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998; 96: 431-450, discussion 450-453
21. Flynn JT, Woodruff G, Thompson JR et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc 1999; 97: 373-390
22. Gandjour A, Schlichtherle S, Neugebauer A et al. A cost-effectiveness model of screening strategies for amblyopia and risk factors and its application in a german setting. Optom Vis Sci 2003; 80: 259-269
23. Groeneveld PW, Lieu TA, Fendrick AM et al. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol 2001; 96: 338-347
24. Hartmann EE, Dobson V, Hainline L et al. Preschool vision screening: summary of a Task Force report. Behalf of the Maternal and Child Health Bureau and the National Eye Institute Task Force on Vision Screening in the Preschool Child. Pediatrics 2000; 106: 1105-1116
25. Harvard Center for Risk Analysis - School of Public Health. The CEA Registry: "Panel-worthy" Table of Cost-Utility Ratios 1976-1997 (PDF). http://www.hsph.harvard.edu/cearegistry (Stand 7.5.2004).
26. Hillis A, Flynn JT, Hawkins BS. The evolving concept of amblyopia: a challenge to epidemiologists. Am J Epidemiol 1983; 118: 192-205
27. Hirneiss C, Neubauer AS, Welge-Lussen U et al. Bestimmung der Lebensqualität des Patienten in der Augenheilkunde. Ophthalmologe 2003; 100: 1091-1097
28. Holmes JM, Kraker RT, Beck RW et al. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 110: 2075-2087
29. Jager GJ, Severens JL, Thornbury JR et al. Prostate cancer staging: should MR imaging be used? - A decision analytic approach. Radiology 2000; 215: 445-451
30. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996; 124: 164-169
31. Kasmann-Kellner B, Heine M, Pfau B et al. Screening-Untersuchung auf Amblyopie, Strabismus und Refraktionsanomalie bei 1030 Kindergartenkindern. Klin Monatsbl Augenheilkd 1998; 213: 166-173
32. Konig HH, Barry JC. Economic evaluation of different methods of screening for amblyopia in kindergarten. Pediatrics 2002; 109: e59
33. Konig HH, Barry JC. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model. Br J Ophthalmol 2004; 88: 606-612
34. Konig HH, Barry JC. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany. Pediatrics 2004; 113: e95-108
35. Konig HH, Barry JC, Leidl R et al. Economic evaluation of orthoptic screening: results of a field study in 121 German kindergartens. Invest Ophthalmol Vis Sci 2002; 43: 3209-3215
36. Konig HH, Walter HS, Barry JC. Ressourcenverbrauch und Kosten der Amblyopiebehandlung. Klin Monatsbl Augenheilkd 2003; 220: 486-491
37. Koskela PU, Mikkola T, Laatikainen L. Permanent results of pleoptic treatment. Acta Ophthalmol (Copenh) 1991; 69: 39-44
38. Kvarnstrom G, Jakobsson P, Lennerstrand G. Screening for visual and ocular disorders in children, evaluation of the system in Sweden. Acta Paediatr 1998; 87: 1173-1179
39. Kvarnstrom G, Jakobsson P, Lennerstrand G. Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand 2001; 79: 240-244
40. Latvala ML, Paloheimo M, Karma A. Screening of amblyopic children and long-term follow-up. Acta Ophthalmol Scand 1996; 74: 488-492
41. Leiba H, Shimshoni M, Oliver M et al. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001; 108: 1552-1555
42. Leibowitz HM, Krueger DE, Maunder LR et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980; 24: 335-610
43. Lieu TA, Gurley RJ, Lundstrom RJ et al. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1741-1750
44. Membreno JH, Brown MM, Brown GC et al. A cost-utility analysis of therapy for amblyopia. Ophthalmology 2002; 109: 2265-2271
45. Montgomery AA, Fahey T, Ben-Shlomo Y et al. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis. J Hypertens 2003; 21: 1753-1759
46. Morgan KS, Kennemer JC. Off-axis photorefractive eye screening in children. J Cataract Refract Surg 1997; 23: 423-428
47. Murthy GV, Gupta SK, Ellwein LB et al. Refractive error in children in an urban population in New Delhi. Invest Ophthalmol Vis Sci 2002; 43: 623-631
48. Newman DK, Hitchcock A, McCarthy H et al. Preschool vision screening: outcome of children referred to the hospital eye service. Br J Ophthalmol 1996; 80: 1077-1082
49. Oliver M, Nawratzki I. Screening of pre-school children for ocular anomalies. II. Amblyopia. Prevalence and therapeutic results at different ages. Br J Ophthalmol 1971; 55: 467-471
50. Schlichtherle S, Gandjour A, Neugebauer A et al. The cost-effectiveness of screening strategies for amblyopia: a preliminary report. Strabismus 2000; 8: 291-295
51. Schmidt P, Maguire M, Dobson V et al. Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision In Preschoolers Study. Ophthalmology 2004; 111: 637-650
52. Sharma S, Brown GC, Brown MM et al. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001; 108: 2051-2059
53. Snowdon SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess 1997; 1: i-iv, 1-83
54. Thorburn R, Roland M. The effectiveness of preschool vision screening by health visitors. Br J Community Nurs 2000; 5: 41-44
55. Williams C, Harrad RA, Harvey I et al. Methodology for a randomised controlled trial of preschool vision screening. A new approach with the 'ALSPAC' project. Ophthalmic Epidemiol 1996; 3: 63-76
56. Williams C, Harrad RA, Harvey I et al. Screening for amblyopia in preschool children: results of a population-based, randomised controlled trial. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Ophthalmic Epidemiol 2001; 8: 279-295
57. Williams C, Northstone K, Harrad RA et al. Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study. Br J Ophthalmol 2003; 87: 988-993